CBC Group logo

CBC Group

Asia, Central Region, Singapore, Singapore

Description

CBC Group is a healthcare-dedicated investment firm that creates value and integrates global resources.

Investor Profile

CBC Group has made 3 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (67%)
  • Series A (33%)

Country Focus

  • China (67%)
  • United States (33%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Oncology
  • Health Care
  • Pharmaceutical
  • Manufacturing
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does CBC Group frequently co-invest with?

Mitsui & Co
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
A
North America, Massachusetts, United States, Waltham
Co-Investments: 1
Cenova
Asia, Shanghai, China, Shanghai
Co-Investments: 1
F-Prime Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
YF Capital
Asia, Shanghai, China, Jingan
Co-Investments: 2
GGV Capital
North America, California, United States, Menlo Park
Co-Investments: 1
Co-Investments: 1
Eight Roads Ventures
Europe, England, United Kingdom, London
Co-Investments: 1
Pavilion Capital
North America, New York, United States, New York
Co-Investments: 1
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 1

What are some of recent deals done by CBC Group?

Sironax

Beijing, Beijing, China

Sironax is a clinical-stage biotechnology company that develops novel products and treatments for age-related degenerative diseases.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series BAug 2, 2022
Amount Raised: $200,000,000
Axbio

Shenzhen, Guangdong, China

Axbio manufactures next-generation gene sequencing and diagnostic high-end equipment and providing complete industrial solutions.

ManufacturingMedical Device
Series BJun 20, 2022
Amount Raised: $100,000,000
ENSEM Therapeutics

Medford, Massachusetts, United States

ENSEM Therapeutics is a biotechnology company focusing on high value and difficult-to-drug oncology targets

BiotechnologyOncologyTherapeutics
Series AApr 6, 2022
Amount Raised: $67,000,000